�Researchers from UQ's Queensland Brain Institute are set to deport a world-first trial into the connexion between antepartum vitamin D levels and schizophrenia prevalence.
Funded by the NHMRC and lED by QBI's Dr Darryl Eyles, a team of four researchers will study blood floater taken from newborn babies who hold gone on to develop schizophrenia in early maturity.
"Undeniably, dispirited maternal vitamin D affects the way the brain develops," Dr Eyles aforesaid.
"Over the past four years we've been able to point that low vitamin D intake in animals during pregnancy results in issue with mind abnormalities alike to those seen in patients with schizophrenia."
The next step of the research process involves testing the theory on human samples.
By analysing the blood spots of newborns the team will suffer a good indication of the baby's vitamin D status at the time of nativity.
This type of study is possible thanks to a biobank located at the Statens Serum Institute in Copenhagen where the Danish government have not only stored newborn blood spots since 1981, but kept ongoing medical records which come with each sampling.
"This is a straight test of the
